Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Medical Developments International Limited ABN/ARBN Financial year ended: 106340667 30.06.26 Our corporate...
Appendix 4G 2026
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4g-2026-4
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
Earlier from Medical Developments International
- Notification of cessation of securities - MVP
- Date of AGM and Closing Date for Director Nominations
- MVP Announces FY26 Full Year Results
- FY26 Full year Results Investor Presentation
- FY26 Full Year Results
Later from Medical Developments International
- Annual Report 2026
- Notice of Annual General Meeting 2026
- Corporate Governance Statement 2026
- CEO Transition
- Appendix 4C and Quarterly Activity Report -30 September 2026
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International